Skip to content

Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)

Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06926959
Enrollment
3000
Registered
2025-04-15
Start date
2016-06-15
Completion date
2030-06-15
Last updated
2025-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tricuspid Regurgitation

Keywords

Tricuspid Regurgitation, all-cause mortality, risk factor, prediction model

Brief summary

This study is a multicenter cohort study including patients diagnosed with tricuspid regurgitation during hospitalization. The primary outcome of the study is all-cause death, and the secondary outcome is cardiovascular events. The prognostic risk factors of patients with tricuspid regurgitation are evaluated, and the prognostic models are constructed through the follow-up observation.

Interventions

None listed

Sponsors

First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Third Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Affiliated Hospital of Guangdong Medical University
CollaboratorOTHER
Second Affiliated Hospital of Shantou University Medical College
CollaboratorOTHER
Eighth Affiliated Hospital, Sun Yat-sen University
CollaboratorOTHER
Zhongshan People's Hospital, Guangdong, China
CollaboratorOTHER
Jieyang People's Hospital
CollaboratorOTHER
Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Aged over 18 yrs. * Patients diagnosed with tricuspid regurgitation during hospitalization.

Exclusion criteria

* Patients unable to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
all-cause mortalityThrough study completion, an average of 5 yearsDeath due to any cause after enrollment

Secondary

MeasureTime frameDescription
Cardiovascular deathThrough study completion, an average of 5 yearsDeath caused by cardiac causes
Heart Failure HospitalizationThrough study completion, an average of 5 yearsHospitalization with the primary reason for admission as acute decompensated HF and administration of intravenous or mechanical heart failure therapies.

Countries

China

Contacts

Primary ContactXiaodong Zhuang
zhuangxd3@mail.sysu.edu.cn+8613760755035

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026